Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05703256 · ClinicalTrials.gov registry record · NA

Amygdala Neurofeedback for Depression - Large Scale Clinical Trial

A NA study of Major Depressive Disorder, sponsored by Kymberly Young.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05703256 is a NA study of Major Depressive Disorder that is actively recruiting participants, run by Kymberly Young. The registered enrollment target is 200 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05703256, a NA study of Major Depressive Disorder, is actively recruiting participants, sponsored by Kymberly Young.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as a stand-alone intervention for major depressive disorder

Conditions Studied

Interventions

  • DEVICE Amygdala real-time fMRI neurofeedback
  • DEVICE Sham feedback

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-06-01
Est. Completion 2028-04-30
Phase NA

Sponsor

Kymberly Young

4 total trials

What the Registry Record Tells You About NCT05703256

The ClinicalTrials.gov registry entry for NCT05703256 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (47% lower). The listed sponsor is Kymberly Young, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Amygdala real-time fMRI neurofeedback is the first listed.

NCT05703256 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05703256 about?

NCT05703256 is a clinical study titled "Amygdala Neurofeedback for Depression - Large Scale Clinical Trial". The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as a stand-alone intervention for major depressive disorder

What is the current status of trial NCT05703256?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-06-01. Estimated completion is 2028-04-30.

What conditions does trial NCT05703256 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT05703256?

The interventions under investigation include: Amygdala real-time fMRI neurofeedback (DEVICE), Sham feedback (DEVICE).

Who is sponsoring clinical trial NCT05703256?

This trial is sponsored by Kymberly Young, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05703256 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.